Paragon 28, Inc. (NYSE:FNA – Get Free Report) saw a large increase in short interest in June. As of June 15th, there was short interest totalling 5,300,000 shares, an increase of 14.0% from the May 31st total of 4,650,000 shares. Currently, 14.3% of the company’s stock are short sold. Based on an average trading volume of 720,500 shares, the days-to-cover ratio is currently 7.4 days.
Analyst Upgrades and Downgrades
A number of research analysts have commented on FNA shares. JMP Securities lowered their target price on Paragon 28 from $23.00 to $20.00 and set a “market outperform” rating on the stock in a research note on Thursday, May 9th. Piper Sandler reissued an “overweight” rating and issued a $15.00 price target (down previously from $18.00) on shares of Paragon 28 in a research note on Thursday, May 9th. Stephens reaffirmed an “overweight” rating and set a $18.00 price objective on shares of Paragon 28 in a research report on Friday, April 5th. Finally, Needham & Company LLC decreased their target price on shares of Paragon 28 from $17.00 to $14.00 and set a “buy” rating for the company in a research report on Thursday, May 9th. Five equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus target price of $16.75.
Read Our Latest Analysis on FNA
Institutional Trading of Paragon 28
Paragon 28 Stock Down 1.8 %
Shares of FNA traded down $0.12 during trading hours on Wednesday, hitting $6.50. 51,314 shares of the company were exchanged, compared to its average volume of 614,631. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.78 and a current ratio of 3.57. The firm’s 50 day moving average is $7.65 and its 200-day moving average is $10.27. Paragon 28 has a 52 week low of $5.55 and a 52 week high of $18.50.
Paragon 28 (NYSE:FNA – Get Free Report) last posted its earnings results on Wednesday, May 8th. The company reported ($0.18) earnings per share for the quarter, missing the consensus estimate of ($0.11) by ($0.07). Paragon 28 had a negative return on equity of 27.72% and a negative net margin of 24.45%. The company had revenue of $61.08 million during the quarter. As a group, equities analysts forecast that Paragon 28 will post -0.58 EPS for the current year.
Paragon 28 Company Profile
Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.
Read More
- Five stocks we like better than Paragon 28
- What Are the FAANG Stocks and Are They Good Investments?
- Is Rivian Stock on the Verge of a 100% Rally?
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Clarivate: The Cheapest AI Stock Worth Buying?
- What is a Secondary Public Offering? What Investors Need to Know
- Survey: America’s Top 100 Hidden Gem Cities for Startups
Receive News & Ratings for Paragon 28 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paragon 28 and related companies with MarketBeat.com's FREE daily email newsletter.